Teva Pharmaceutical

Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?
Novo's Victoza won't face Teva copies until 2023. Can semaglutide fill the gap by then?
Fierce Pharma
Novo Nordisk
diabetes
Teva Pharmaceutical
Victoza
semaglutide
Flag link:
FDA Warns Teva Subsidiary Over Quality Failures, CGMP Violations
FDA Warns Teva Subsidiary Over Quality Failures, CGMP Violations
RAPS.org
Teva Pharmaceutical
Actavis
FDA
drug manufacturing
Flag link:
Teva launches generic for Pfizer’s Flector pain patch
Teva launches generic for Pfizer’s Flector pain patch
Drug Delivery Business News
Teva Pharmaceutical
generics
Pfizer
Flector
pain patches
Flag link:
Teva aims for 25% of U.S. EpiPen market by 2020
Teva aims for 25% of U.S. EpiPen market by 2020
Drug Delivery Business News
Teva Pharmaceutical
Mylan
EpiPen
generics
Flag link:
Teva set to shed 11 manufacturing sites in 2019
Teva set to shed 11 manufacturing sites in 2019
BioPharma Dive
Teva Pharmaceutical
drug manufacturing
Flag link:
Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down
Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down
Yahoo/Zacks.com
Teva Pharmaceutical
earnings
Flag link:
Teva predicts bleak year ahead as generic, Copaxone sales drop
Teva predicts bleak year ahead as generic, Copaxone sales drop
Biopharma Dive
Teva Pharmaceutical
Copaxone
Flag link:
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
Yahoo/Zacks.com
Teva Pharmaceutical
earnings
Flag link:
CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
Reuters
CVS Health
migraines
Amgen
Teva Pharmaceutical
Eli Lilly
Aimovig
Ajovy
Emgality
Flag link:
Teva wins legal dispute over Aloxi, treatment of chemotherapy-induced nausea
Teva wins legal dispute over Aloxi, treatment of chemotherapy-induced nausea
GoinPharma
Teva Pharmaceutical
Helsinn
Aloxi
chemotherapy-induced nausea and vomiting
patents
Supreme Court
Flag link:
Israeli authorities to demand $271M bill from tax-advantaged Teva: report
Israeli authorities to demand $271M bill from tax-advantaged Teva: report
Fierce Pharma
Teva Pharmaceutical
Israel
taxes
Flag link:
FDA Approves First Generic Version of Lundbeck’s Sabril
FDA Approves First Generic Version of Lundbeck’s Sabril
RAPS.org
FDA
Teva Pharmaceutical
Lundbeck
seizures
generics
Sabril
Vigabatrin
Flag link:
Teva hands over $135M to settle claims of inflated drug prices
Teva hands over $135M to settle claims of inflated drug prices
BioPharma Dive
Teva Pharmaceutical
drug pricing
Illinois
Flag link:
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
Flag link:
Teva shells out $135M to wrap Illinois AG's Medicaid pricing fraud suit
Teva shells out $135M to wrap Illinois AG's Medicaid pricing fraud suit
Fierce Pharma
Teva Pharmaceutical
Medicaid
Illinois
drug pricing
Flag link:
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
JPM recap: Must-reads of the week, from FDA to IPO to M&A and more
Fierce Pharma
JPMHC 2019
Merck
FDA
M&A
Celgene
Bristol-Myers Squibb
Genevant
IPOs
Eli Lilly
Novartis
GSK
Teva Pharmaceutical
Alexion
Pear Therapeutics
Flag link:
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
GoinPharma
Teva Pharmaceutical
debt
JPMHC 2019
Kåre Schultz
Pharma CEOs
Flag link:
Teva and Neos settle over Cotempla patent dispute
Teva and Neos settle over Cotempla patent dispute
Pharmaforum
Teva Pharmaceutical
Neos Therapeutics
generics
patents
ADHD
Cotempla XR-ODT
Flag link:
FDA approves Teva’s digital COPD, asthma inhaler
FDA approves Teva’s digital COPD, asthma inhaler
Drug Delivery Business News
Teva Pharmaceutical
ProAir Digihaler
devices
asthma
COPD
FDA
Flag link:
Teva reports positive results for fremanezumab in phase IIIb migraine trial
Teva reports positive results for fremanezumab in phase IIIb migraine trial
Pharmaceutical Business Review
Teva Pharmaceutical
migraines
clinical trials
fremanezumab
Flag link:

Pages